FIA
XENE icon

FNY Investment Advisers’s Xenon Pharmaceuticals XENE Stock Holding History

FNY Investment Advisers’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
4,000
-200
-5% -$11.1K 0.09% 223
2026
Q1 		$244K Buy
+4,200
New +$194K 0.11% 178

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FNY Investment Advisers's XENE Position: Q2 2026 in Review

FNY Investment Advisers reduced its Xenon Pharmaceuticals (XENE) stake by 4.8% in Q2 2026, selling an estimated $11.1K and leaving 4,000 shares worth $241K. The position accounts for 0.09% of the portfolio, ranked #223.

FNY Investment Advisers first reported a position in XENE in Q1 2026 and has held it in 2 quarters since. The position peaked at $244K in Q1 2026. 99 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • FNY Investment Advisers held 4,000 shares of Xenon Pharmaceuticals worth $241K as of Q2 2026.
  • FNY Investment Advisers sold 200 Xenon Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Xenon Pharmaceuticals made up 0.09% of FNY Investment Advisers's portfolio in Q2 2026, its #223 holding.
  • FNY Investment Advisers first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • FNY Investment Advisers's Xenon Pharmaceuticals position peaked at $244K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.